BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35401831)

  • 1. Hepatic PRMT1 ameliorates diet-induced hepatic steatosis via induction of PGC1α.
    Xu L; Huang Z; Lo TH; Lee JTH; Yang R; Yan X; Ye D; Xu A; Wong CM
    Theranostics; 2022; 12(6):2502-2518. PubMed ID: 35401831
    [No Abstract]   [Full Text] [Related]  

  • 2. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.
    Park MJ; Kim DI; Lim SK; Choi JH; Kim JC; Yoon KC; Lee JB; Lee JH; Han HJ; Choi IP; Kim HC; Park SH
    J Hepatol; 2014 Nov; 61(5):1151-7. PubMed ID: 25003952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neohesperidin enhances PGC-1α-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice.
    Wang SW; Sheng H; Bai YF; Weng YY; Fan XY; Lou LJ; Zhang F
    Nutr Diabetes; 2020 Aug; 10(1):27. PubMed ID: 32759940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REDD1 deficiency protects against nonalcoholic hepatic steatosis induced by high-fat diet.
    Dumas K; Ayachi C; Gilleron J; Lacas-Gervais S; Pastor F; Favier FB; Peraldi P; Vaillant N; Yvan-Charvet L; Bonnafous S; Patouraux S; Anty R; Tran A; Gual P; Cormont M; Tanti JF; Giorgetti-Peraldi S
    FASEB J; 2020 Apr; 34(4):5046-5060. PubMed ID: 32043636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex modulates hepatic mitochondrial adaptations to high-fat diet and physical activity.
    McCoin CS; Von Schulze A; Allen J; Fuller KNZ; Xia Q; Koestler DC; Houchen CJ; Maurer A; Dorn GW; Shankar K; Morris EM; Thyfault JP
    Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E298-E311. PubMed ID: 31039007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis.
    Huang L; Liu J; Zhang XO; Sibley K; Najjar SM; Lee MM; Wu Q
    J Biol Chem; 2018 Jul; 293(28):10884-10894. PubMed ID: 29773653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical role for hepatic protein arginine methyltransferase 1 isoform 2 in glycemic control.
    Ma Y; Liu S; Jun H; Wang J; Fan X; Li G; Yin L; Rui L; Weinman SA; Gong J; Wu J
    FASEB J; 2020 Nov; 34(11):14863-14877. PubMed ID: 32918517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
    Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor-α-mediated fatty acid oxidation.
    Wu X; Zheng H; Yang R; Luan X; Zhang L; Jin Q; Jin Y; Xue J
    Am J Physiol Endocrinol Metab; 2019 Sep; 317(3):E436-E445. PubMed ID: 31211621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (
    Wu M; Lo TH; Li L; Sun J; Deng C; Chan KY; Li X; Yeh ST; Lee JTH; Lui PPY; Xu A; Wong CM
    Elife; 2023 Aug; 12():. PubMed ID: 37580962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of SIRT-1/PGC-1α-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease.
    Jiang Y; Chen D; Gong Q; Xu Q; Pan D; Lu F; Tang Q
    Lipids Health Dis; 2021 Apr; 20(1):40. PubMed ID: 33902605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
    Lee H; Ahn J; Shin SS; Yoon M
    Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-fat diet inhibits PGC-1α suppressive effect on NFκB signaling in hepatocytes.
    Barroso WA; Victorino VJ; Jeremias IC; Petroni RC; Ariga SKK; Salles TA; Barbeiro DF; de Lima TM; de Souza HP
    Eur J Nutr; 2018 Aug; 57(5):1891-1900. PubMed ID: 28540526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
    Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
    J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1α-HO-1-PGC1α-mitochondrial signaling.
    Raffaele M; Bellner L; Singh SP; Favero G; Rezzani R; Rodella LF; Falck JR; Abraham NG; Vanella L
    Exp Cell Res; 2019 Jul; 380(2):180-187. PubMed ID: 31039348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein arginine methyltransferase expression, localization, and activity during disuse-induced skeletal muscle plasticity.
    Stouth DW; Manta A; Ljubicic V
    Am J Physiol Cell Physiol; 2018 Feb; 314(2):C177-C190. PubMed ID: 29092819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin enhancer-binding factor 3 functions as a liver receptor homologue-1 co-activator in synergy with the nuclear receptor co-activators PRMT1 and PGC-1α.
    Ohno M; Komakine J; Suzuki E; Nishizuka M; Osada S; Imagawa M
    Biochem J; 2011 Aug; 437(3):531-40. PubMed ID: 21554248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent restraint-induced sympathetic activation attenuates hepatic steatosis and inflammation in a high-fat diet-fed mouse model.
    Lee SB; Kim HG; Lee JS; Kim WY; Lee MM; Kim YH; Lee JO; Kim HS; Son CG
    Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G811-G823. PubMed ID: 31604029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.